John Brendan Doyle - 03 Feb 2026 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
Chief Financial Officer
Signature
/s/ John Brendan Doyle
Issuer symbol
CGTX
Transactions as of
03 Feb 2026
Net transactions value
-$27,729
Form type
4
Filing time
05 Feb 2026, 17:27:19 UTC
Previous filing
22 Dec 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doyle John Brendan Chief Financial Officer C/O COGNITION THERAPEUTICS INC, 2500 WESTCHESTER AVE., PURCHASE /s/ John Brendan Doyle 05 Feb 2026 0001840738

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGTX Common Stock Award $0 +200,000 +45% $0.000000 645,990 03 Feb 2026 Direct F1
transaction CGTX Common Stock Tax liability $27,729 -26,921 -4.2% $1.03 619,069 04 Feb 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.